Skip to main content
Corporate policies & ESG reporting

Responsibility

Browse:

These policies and ESG reports highlight our responsibility to patients, employees, the environment and local communities. They allow us to integrate corporate responsibility into efforts across our business landscape and employee experience. 

Woman sitting on couch and smiling
Pipet filling Erlenmeyer Flask with red liquid

Our policies

Icon - Healthcare - Vaccine

Access to medicine

We’re committed to optimizing the impact of mRNA vaccines and therapeutics through fair pricing and access for all.

Icon - Humanity - Personal Chart

Human rights

As a company at the forefront of developing medicines for patients across the world, we have an obligation to purposefully uphold human rights.

Icon - Business - Paper

Political engagement policy

We do not make direct contributions to political campaigns or candidates, and are committed to transparency on our engagement with trade associations and other advocacy organizations.

Icon - Business - Certificate

Code of Ethics and Business Conduct

Ensuring all employees act ethically and legally in their business decisions and day-to-day duties is crucial to carrying out our mission.

Icon - Business - Notebooks

Corporate governance guidelines

We believe sound governance practices and policies are important to our success as a company and to obtaining the trust of our stakeholders.

Icon - Business - Personal Chart

CEO action for diversity & inclusion pledge

We’ve pledged to act on supporting more inclusive workplaces because we know that success is rooted in diverse viewpoints.

Icon - Business - Notebook

Government funding and vaccine access

Learn more about how we have approached access and pricing for our COVID-19 vaccine, including as a result of government funding.

Icon - Business - Notebook

Modern slavery statement

We are committed to addressing and preventing modern slavery within our business and our supply chain.

Icon - Humanity - Personal Chart

Global transparency disclosures

We are committed to complying with applicable laws, regulations and codes of conduct governing the transparency of our interactions with healthcare professionals and organizations and patient advocacy organizations ensuring public trust and confidence.

Icon - Healthcare - Vaccine

Expanded Access

For patients who do not qualify for clinical trials, Moderna may open an expanded access program for a medication prior to its approval. Currently, we do not have expanded access programs open for our medications. Please check back for updates.

Icon - Business - Notebook

Third Party Code of Business Conduct

We strive to work with partners who bring value to Moderna and align with our high ethical standards and values.

Icon - Business - Certificate

Global Environment, Health, and Safety Policy

We are committed to creating a safe and healthy workplace and act with urgency to help protect and preserve the environment

Icon - Business - Notebook

Anti-Bribery / Anti-Corruption Policy

We prioritize ethics and integrity, and have zero tolerance for corruption, including bribery and unethical practices. This policy guides us as we comply with laws worldwide keeping our values, trust and patients' well-being at the center of all we do.

Icon - Business - Notebook

AI Code of Conduct

Moderna's AI Code of Conduct outlines our commitment to the responsible development and use of artificial intelligence, emphasizing our base camp values of integrity, quality, and respect.

Icon - Business - Notebook

Summary of Trade Compliance

ESG Reporting

Icon - Business - Paper

2023 ESG report

We are committed to transparency about our ESG efforts and progress right from the start of our journey.

Icon - Business - Paper

U.S. EEO-1 report

We publicly disclose our consolidated EEO-1 reports for our U.S. workforce. Our most recent filings capture employer information in conformance with the U.S. Department of Labor regulations and requirements for such reporting.

Icon - Business - Paper

Moderna Environmental Data

An assessment of Moderna’s environmental metrics for 2021, 2022, and 2023.